Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17442 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, 2023. Written by Pierfrancesco Visaggi and 1 co-authors. Institution: Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Major MEDLINE topics: Eosinophilic Esophagitis. Cited 4 times so far (Crossref); 10 references.
Abstract (original language)
LINKED CONTENT This article is linked to Hirano et al papers. To view these articles, visit https://doi.org/10.1111/apt.17430 and https://doi.org/10.1111/apt.17476
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
- Gastroenterology Unit, Azienda Ospedale Università di Padova, Padua, Italy.
ORCID profiles: Pierfrancesco Visaggi, Edoardo Vincenzo Savarino
Cite
APA
Visaggi, P., & Savarino, E. V. (2023). Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17442
Vancouver
Visaggi P, Savarino EV. Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17442
BibTeX
@article{Visaggi2023,
author = {Visaggi, Pierfrancesco and Savarino, Edoardo Vincenzo},
title = {Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17442}
}
EUVIMED